UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053844
Receipt number R000061425
Scientific Title Evaluation of female sexual function and desire among controlled and uncontrolled hypertensive female patients: a prospective randomized control study
Date of disclosure of the study information 2024/03/13
Last modified on 2024/03/13 08:17:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of female sexual function and desire among controlled and uncontrolled hypertensive female patients: a prospective randomized control study

Acronym

Evaluation of female sexual function and desire among controlled and uncontrolled hypertensive female patients: a prospective randomized control study

Scientific Title

Evaluation of female sexual function and desire among controlled and uncontrolled hypertensive female patients: a prospective randomized control study

Scientific Title:Acronym

Evaluation of female sexual function and desire among controlled and uncontrolled hypertensive female patients: a prospective randomized control study

Region

Africa


Condition

Condition

female sexual dysfunction

Classification by specialty

Cardiology Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To identify the presence of sexual dysfunction in hypertensive women

Basic objectives2

Others

Basic objectives -Others

To identify the relationship of FSD & antihypertensive drugs (Beta Blockers & Angiotensin converting enzyme inhibitors/Angiotensin receptor blockers)

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

To identify the presence of sexual dysfunction in hypertensive women

Key secondary outcomes

to identify the relationship of FSD & antihypertensive drugs (Beta Blockers & Angiotensin converting enzyme inhibitors/Angiotensin receptor blockers)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

5

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

25 Normotensive female controls

Interventions/Control_2

25 Hypertensive female receiving BB & controlled

Interventions/Control_3

25 Hypertensive female receiving BB & uncontrolled

Interventions/Control_4

25 Hypertensive female receiving ACEI/ARBs & controlled

Interventions/Control_5

25 Hypertensive female receiving ACEI/ARBs & uncontrolled

Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

45 years-old >=

Gender

Female

Key inclusion criteria

18 years to 45 years

Key exclusion criteria

breastfeeding women
diabetes mellitus
Obesity
smoking
history of breast cancer or thromboembolic diseases
major cardiovascular disease non-cardiovascular disease
non-sexually active women

Target sample size

125


Research contact person

Name of lead principal investigator

1st name Sameh
Middle name Fayek
Last name GamalEl Din

Organization

Cairo university

Division name

Andrology & STDs

Zip code

002

Address

South academy, New cairo, Cairo

TEL

002025729584

Email

samehfayek@kasralainy.edu.eg


Public contact

Name of contact person

1st name Sameh
Middle name Fayek
Last name GamalEl Din

Organization

Cairo University

Division name

Andrology & STDs

Zip code

002

Address

South academy, New cairo, Cairo

TEL

002025729584

Homepage URL

http://scholar.cu.edu.eg/sfayek

Email

samehfayek@kasralainy.edu.eg


Sponsor or person

Institute

Cairo university

Institute

Department

Personal name

sameh fayek gamalEl Din


Funding Source

Organization

Cairo university

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Cairo university

Address

South academy, New cairo, Cairo

Tel

0020 25 729 584

Email

samehfayek@kasralainy.edu.eg


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 03 Month 03 Day

Date of IRB

2024 Year 03 Month 03 Day

Anticipated trial start date

2024 Year 03 Month 03 Day

Last follow-up date

2025 Year 06 Month 14 Day

Date of closure to data entry

2025 Year 06 Month 14 Day

Date trial data considered complete

2025 Year 06 Month 14 Day

Date analysis concluded

2025 Year 07 Month 10 Day


Other

Other related information



Management information

Registered date

2024 Year 03 Month 13 Day

Last modified on

2024 Year 03 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061425


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name